|
Name |
1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-Hexadecamethyloctasiloxane
|
| Molecular Formula | C16H48O7Si8 | |
| IUPAC Name* |
NA
|
|
| SMILES |
C[Si](C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)C
|
|
| InChI |
InChI=1S/C16H48O7Si8/c1-24(2)17-26(5,6)19-28(9,10)21-30(13,14)23-31(15,16)22-29(11,12)20-27(7,8)18-25(3)4/h1-16H3
|
|
| InChIKey |
JETFAOWLNCGULZ-UHFFFAOYSA-N
|
|
| Synonyms |
1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-Hexadecamethyloctasiloxane; 19095-24-0; Octasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyl-; SCHEMBL9004501; 1H,15H-Hexadecamethyloctasiloxane; DTXSID301017172; AMY42191; MFCD28901346; AS-49444; CS-0199015; A880393; 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-hexadecamethyl octasiloxane; 1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-Hexadecamethyloctasiloxane #; OCTASILOXANE,1,1,3,3,5,5,7,7,9,9,11,11,13,13,15,15-HEXADECAMETHYL-; 2,4,4,6,6,8,8,10,10,12,12,14,14,16-tetradecamethyl-3,5,7,9,11,13,15-heptaoxa-2,4,6,8,10,12,14,16-octasilaheptadecane
|
|
| CAS | 19095-24-0 | |
| PubChem CID | 6329087 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 577.2 | ALogp: | 5.8 |
| HBD: | 0 | HBA: | 7 |
| Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 64.6 | Aromatic Rings: | 0 |
| Heavy Atoms: | 31 | QED Weighted: | 0.238 |
| Caco-2 Permeability: | -5.967 | MDCK Permeability: | 0.00007440 |
| Pgp-inhibitor: | 0.047 | Pgp-substrate: | 0.956 |
| Human Intestinal Absorption (HIA): | 0.996 | 20% Bioavailability (F20%): | 0.015 |
| 30% Bioavailability (F30%): | 0.008 |
| Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 116.63% |
| Volume Distribution (VD): | 3.856 | Fu: | 26.12% |
| CYP1A2-inhibitor: | 0.203 | CYP1A2-substrate: | 0.97 |
| CYP2C19-inhibitor: | 0.856 | CYP2C19-substrate: | 0.974 |
| CYP2C9-inhibitor: | 0.884 | CYP2C9-substrate: | 0.972 |
| CYP2D6-inhibitor: | 0.009 | CYP2D6-substrate: | 0.942 |
| CYP3A4-inhibitor: | 0.574 | CYP3A4-substrate: | 0.08 |
| Clearance (CL): | 2.534 | Half-life (T1/2): | 0.231 |
| hERG Blockers: | 0.486 | Human Hepatotoxicity (H-HT): | 0.002 |
| Drug-inuced Liver Injury (DILI): | 0.012 | AMES Toxicity: | 0.023 |
| Rat Oral Acute Toxicity: | 0 | Maximum Recommended Daily Dose: | 0.255 |
| Skin Sensitization: | 0.853 | Carcinogencity: | 0.017 |
| Eye Corrosion: | 1 | Eye Irritation: | 0.998 |
| Respiratory Toxicity: | 0.022 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001784 | ![]() |
0.870 | D06IGU | ![]() |
0.096 | ||
| ENC001785 | ![]() |
0.740 | D0Z1ZM | ![]() |
0.092 | ||
| ENC000373 | ![]() |
0.644 | D0H2DQ | ![]() |
0.092 | ||
| ENC001271 | ![]() |
0.418 | D06ZUP | ![]() |
0.089 | ||
| ENC000530 | ![]() |
0.407 | D03HJK | ![]() |
0.087 | ||
| ENC003080 | ![]() |
0.290 | D06EEL | ![]() |
0.085 | ||
| ENC003081 | ![]() |
0.245 | D02YIZ | ![]() |
0.082 | ||
| ENC001404 | ![]() |
0.235 | D04JMQ | ![]() |
0.082 | ||
| ENC001122 | ![]() |
0.224 | D0Y7TO | ![]() |
0.080 | ||
| ENC001182 | ![]() |
0.224 | D0E4SI | ![]() |
0.075 | ||